Hillsdale Investment Management Inc.

Position in ENTA — Enanta Pharmaceuticals Inc

CIK 1368465 Toronto, A6

Position in ENTA

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$6,823,440

+$1,322,949 QoQ

Shares Held

468,000

+7.5% QoQ

Ownership

1.61%

of shares outstanding

% of Portfolio

0.16%

of 13F equity value

Holder Rank

#15

of 121 holders

Holding Since

Dec 2021

8 quarters on record

Voting authority Sole 86% Shared 0% None 14%

Healthcare · as of Jun 30, 2026

Hillsdale Investment Management Inc. holds $115,919,445 across 23 Biotechnology names. ENTA ranks #8 (5.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AXSM	Axsome Therapeutics, Inc.	55,000	$13,462,350
2	BBIO	BridgeBio Pharma, Inc.	169,112	$12,595,461
3	MRVI	Maravai Lifesciences Holdings, Inc.	1,682,878	$10,501,158
4	ZYME	Zymeworks Inc.	382,922	$10,009,581
5	TVTX	Travere Therapeutics, Inc.	167,900	$9,538,399
6	AUPH	Aurinia Pharmaceuticals Inc.	550,900	$9,348,773
7	MIRM	Mirum Pharmaceuticals, Inc.	58,630	$6,863,814
8	ENTA	Enanta Pharmaceuticals Inc This page	468,000	$6,823,440

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$6,823,440	468,000	+7.5%	Shares	Sole	2026-08-12
2026-03-31	$5,500,491	435,510	+3.1%	Shares	Sole	2026-05-04
2025-12-31	$6,659,671	422,300	+692.3%	Shares	Sole	2026-02-10
2022-12-31	$2,479,516	53,300	0.0%	Shares	Sole	2023-02-13
2022-09-30	$2,764,671	53,300	0.0%	Shares	Sole	2022-11-10
2022-06-30	$2,519,491	53,300	0.0%	Shares	Sole	2022-08-12
2022-03-31	$3,793,894	53,300	-1.2%	Shares	Sole	2022-04-28
2021-12-31	$4,034,381	53,950	—	Shares	Sole	2022-02-07
No filing history on record for this holder in this stock.